Company
Cadeo Oncology
We create improved treatment options for cancer patients through unique immunotherapy opportunities
Also known as Caedo Oncology
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Founded
- 2020
Claim, correct or request removal
Record updated 28 September 2026
About
Our vision is to be a leader in cancer immunotherapy improving patient treatment through novel monoclonal antibodies, inducing programmed cell death in cancer cells.
Products
- Other
- CO-1
Loading relationship preview